Arkolith/Insider Trading/KPTI/Form 4

Rangwala Reshma

EVP & Chief Medical OfficerKaryopharm Therapeutics Inc. (KPTI) · full profile →Form 4 · filed Mar 6, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2025Sell(S)4K$6.29$23K29K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-034732) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML